Cas no 67627-19-4 (Indigotetrasulfonate tetrapotassiumsalt)
Indigotetrasulfonate tetrapotassiumsalt Chemical and Physical Properties
Names and Identifiers
-
- POTASSIUM INDIGOTETRASULFONATE
- [D2,2'-Biindoline]-5,5'-disulfonicacid,3,3'-dioxo-(7CI,8CI)
- 1H-Indole-5-sulfonicacid,2-(1,3-dihydro-3-oxo-5-sulfo-2H-indol-2-ylidene)-2,3-dihydro-3-oxo
- 3,3'-Dioxo-1,3,1',3'-tetrahydro-[2,2']biindolyliden-5,7,5',7'-te
- 3,3'-dioxo-1,3,1',3'-tetrahydro-[2,2']biindolylidene-5,5'-disulfonic acid
- 3,3'-dioxo-1,3,1',3'-tetrahydro-[2,2']biindolylidene-5,7,5',7'-tetrasulfonic acid,tetrapotassium salt
- indigo carmine
- Indigodisulfonic acid
- Saxon blue
- Tetrapotassium Indigotetrasulfonate
- tetrapotassium;2-(3-hydroxy-5,7-disulfonato-1H-indol-2-yl)-3-oxoindole-5,7-disulfonate
- Indigotetrasulfonic Acid Tetrapotassium Salt
- 5,5',7,7'-Indigotetrasulfonic acid tetrapotassium salt
- Potassium indigotetrasulfonate, Dye content 85 %
- MFCD00059886
- Potassium 3,3'-dioxo-[2,2'-biindolinylidene]-5,5',7,7'-tetrasulfonate
- 1H-Indoledisulfonic acid, 2-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-2,3-dihydro-3-oxo-, disulfo deriv., potassium salt (1:4)
- I0019
- 28699-96-9
- 67627-19-4
- Indigotetrasulfonate tetrapotassiumsalt
-
- Inchi： 1S/C16H10N2O14S4.4K/c19-15-7-1-5(33(21,22)23)3-9(35(27,28)29)11(7)17-13(15)14-16(20)8-2-6(34(24,25)26)4-10(12(8)18-14)36(30,31)32;;;;/h1-4,17,19H,(H,21,22,23)(H,24,25,26)(H,27,28,29)(H,30,31,32);;;;/q;4*+1/p-4
- InChI Key： YWCAPYLKURBDGO-UHFFFAOYSA-J
- SMILES： [K+].[K+].[K+].[K+].S(C1=CC(=CC2C(=C(C3C(C4C=C(C=C(C=4N=3)S(=O)(=O)[O-])S(=O)(=O)[O-])=O)NC=21)O)S(=O)(=O)[O-])(=O)(=O)[O-]
Computed Properties
- Exact Mass: 733.72500
- Monoisotopic Mass: 733.7250135g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 16
- Heavy Atom Count: 40
- Rotatable Bond Count: 4
- Complexity: 1290
- Covalently-Bonded Unit Count: 5
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- XLogP3: Not available
- Topological Polar Surface Area: 287
Experimental Properties
- Color/Form: Not available
- PSA: 320.52000
- LogP: 3.03040
- Solubility: Not available
Indigotetrasulfonate tetrapotassiumsalt Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | I248995-250mg |
Indigotetrasulfonate tetrapotassiumsalt |
67627-19-4 | 250mg |
$ 230.00 | 2022-06-04 | ||
| TRC | I248995-500mg |
Indigotetrasulfonate tetrapotassiumsalt |
67627-19-4 | 500mg |
$ 375.00 | 2022-06-04 | ||
| TRC | I248995-1000mg |
Indigotetrasulfonate tetrapotassiumsalt |
67627-19-4 | 1g |
$ 600.00 | 2022-06-04 | ||
| SHENG KE LU SI SHENG WU JI SHU | sc-215740-1g |
Potassium indigotetrasulfonate, |
67627-19-4 | 1g |
￥677.00 | 2023-09-05 | ||
| SHENG KE LU SI SHENG WU JI SHU | sc-215740-1 g |
Potassium indigotetrasulfonate, |
67627-19-4 | 1g |
￥677.00 | 2023-07-11 |
Indigotetrasulfonate tetrapotassiumsalt Related Literature
-
Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
-
Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
-
3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
-
Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
-
Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
Additional information on Indigotetrasulfonate tetrapotassiumsalt
Recent Advances in the Study of Indigotetrasulfonate Tetrapotassium Salt (CAS: 67627-19-4)
Indigotetrasulfonate tetrapotassium salt (CAS: 67627-19-4) is a synthetic dye with significant applications in the field of chemical biology and medicine. Recent studies have explored its potential as a diagnostic agent, therapeutic compound, and research tool due to its unique chemical properties and biological interactions. This research brief synthesizes the latest findings on this compound, highlighting its mechanisms of action, applications, and future directions in biomedical research.
One of the most notable advancements in the study of indigotetrasulfonate tetrapotassium salt is its role in diagnostic imaging. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as a contrast agent in magnetic resonance imaging (MRI). The compound's ability to bind selectively to certain tissues and enhance imaging contrast has opened new avenues for non-invasive diagnostic techniques. Researchers have also investigated its potential in fluorescence-based assays, where its stable emission spectra make it a reliable marker for cellular studies.
In addition to diagnostic applications, indigotetrasulfonate tetrapotassium salt has shown promise in therapeutic contexts. A recent preclinical study published in Bioorganic & Medicinal Chemistry Letters explored its anti-inflammatory properties. The compound was found to inhibit key inflammatory pathways, suggesting potential utility in treating chronic inflammatory diseases. Furthermore, its low toxicity profile in animal models supports its candidacy for further drug development. These findings are particularly relevant given the growing need for novel anti-inflammatory agents with minimal side effects.
The chemical stability and solubility of indigotetrasulfonate tetrapotassium salt have also made it a valuable tool in biochemical research. A 2024 study in Analytical Biochemistry utilized the compound as a redox indicator in enzymatic assays. Its distinct color change under varying redox conditions provides a simple yet effective means of monitoring enzymatic activity. This application underscores the compound's versatility beyond its traditional uses in staining and labeling.
Despite these advancements, challenges remain in the widespread adoption of indigotetrasulfonate tetrapotassium salt. Issues such as batch-to-batch variability in synthesis and potential interactions with other biomolecules require further investigation. Ongoing research aims to optimize synthesis protocols and explore its interactions at the molecular level. Collaborative efforts between chemists, biologists, and clinicians will be essential to fully realize the potential of this compound.
In conclusion, indigotetrasulfonate tetrapotassium salt (CAS: 67627-19-4) represents a multifaceted compound with significant implications for chemical biology and medicine. Its applications in diagnostics, therapeutics, and research tools highlight its versatility and potential for future innovations. Continued research and development will be crucial to address existing challenges and unlock new opportunities for this promising compound.
67627-19-4 (Indigotetrasulfonate tetrapotassiumsalt) Related Products
- 13725-33-2(Indigodisulfonic Acid Dipotassium Salt)
- 28699-96-9(Indigotetrasulfonic Acid Tetrapotassium Salt Hydrate)
- 67627-18-3(Indigotrisulfonic Acid Potassium Salt)
- 28606-01-1(1H-Indoledisulfonicacid, 2-(1,3-dihydro-3-oxosulfo-2H-indol-2-ylidene)-2,3-dihydro-3-oxo-,potassium salt (1:3))
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
